Research workbench
Human myeloid-derived growth factor (mydgf) in complex with neutralizing Fab
Analyse Human myeloid-derived growth factor (mydgf) in complex with neutralizing Fab in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 6SVL
- Type
- protein
- Length
- 3,231 residues
- Chains
- 18
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- FAB_HEAVY_CHAIN; FAB_LIGHT_CHAIN; Myeloid-derived growth factor
- UniProt
- Q969H8
- Pockets
- 20 · best druggability 0.82
Structure
x-ray diffraction · 12 distinct chains · 6% helix, 53% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | FAB_HEAVY_CHAIN | protein | 212 | 8% helix, 50% strand | — |
| B | FAB_LIGHT_CHAIN | protein | 210 | 6% helix, 50% strand | — |
| C | Myeloid-derived growth factor | protein | 95 | 3% helix, 51% strand | Q969H8 |
| D, H, K, O | FAB_HEAVY_CHAIN | protein | 213 | 8% helix, 50% strand | — |
| E, I, L, M | FAB_LIGHT_CHAIN | protein | 212 | 6% helix, 51% strand | — |
| F | Myeloid-derived growth factor | protein | 116 | 3% helix, 58% strand | Q969H8 |
| G | FAB_HEAVY_CHAIN | protein | 215 | 8% helix, 51% strand | — |
| J | Myeloid-derived growth factor | protein | 126 | 2% helix, 57% strand | Q969H8 |
| N | Myeloid-derived growth factor | protein | 123 | 5% helix, 59% strand | Q969H8 |
| P | FAB_LIGHT_CHAIN | protein | 191 | 4% helix, 49% strand | — |
| Q | Myeloid-derived growth factor | protein | 123 | 2% helix, 59% strand | Q969H8 |
| R | Myeloid-derived growth factor | protein | 120 | 5% helix, 57% strand | Q969H8 |
Ligands and binding sites
- GOL · Glycerol · additive · 3 copies · chains D, E, M, O, P, R
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
20 pockets found on a 1 Å grid, 18 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 985 | 0.82 | 0.83 | 76 | empty |
| 2 | 860 | 0.72 | 0.77 | 90 | empty |
| 3 | 821 | 0.70 | 0.76 | 70 | empty |
| 4 | 559 | 0.67 | 0.77 | 66 | empty |
| 5 | 484 | 0.67 | 0.79 | 90 | GOL |
Interfaces
40 interfaces between chains.
- O–P · 1871 Ų buried · 12 hydrogen bonds · protein-protein
- G–I · 1869 Ų buried · 15 hydrogen bonds · protein-protein
- D–E · 1862 Ų buried · 16 hydrogen bonds · protein-protein
- H–L · 1857 Ų buried · 14 hydrogen bonds · protein-protein
- A–B · 1846 Ų buried · 15 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 30 disulfide (disulfide).
Compared structures
- 6SVL · human Myeloid-derived growth factor (MYDGF) in complex with neutralizing Fab · the same entry in another collection · chain R against R, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q969H8
- Elsewhere: RCSB PDB 6SVL · PDBe 6SVL · UniProt Q969H8
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.